Predictmedix, a company that provides rapid health screening solutions using artificial intelligence (AI), has announced an update on their non-invasive impairment detection technology for specific industries. The technology, which combines multispectral imaging and speech analysis, has achieved over 90% accuracy in identifying impairment caused by alcohol and/or cannabis. The AI-powered technology identifies signs of impairment and correlates them with various levels of impairment-inducing agents. Predictmedix’s patented technology will be used in their AI-powered mobile app, which works with a portable multispectral imaging camera for non-invasive impairment detection. The company aims to serve global law enforcement agencies, transport, and other high-risk industries where impairment is a significant liability.